FDA.reportPublic FDA data

remifentanil 2 MG Injection

RxCUI
1729584
RxNorm name
remifentanil 2 MG Injection
Display name
remifentanil 2 MG Injection
Full name
remifentanil 2 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UltivaREMIFENTANIL HYDROCHLORIDEMylan Institutional LLC4dbcb8f9-1987-4b66-bd2f-d251fda0be102025-12-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1729584
UltivaREMIFENTANIL HYDROCHLORIDEMylan Institutional LLC8b4c8696-e23e-4c51-a4d2-babab5bd945a2025-12-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1729584
Remifentanil HydrochlorideREMIFENTANIL HYDROCHLORIDEFresenius Kabi USA, LLCd2374b84-81c9-44f9-a4a9-1071281b25312024-09-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1729584
REMIFENTANIL HYDROCHLORIDEREMIFENTANIL HYDROCHLORIDEHikma Pharmaceuticals USA Inc.9d289052-1eb6-4ba2-a3ca-d2e542a052ae2024-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1729584

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d2374b84-81c9-44f9-a4a9-1071281b2531remifentanil 2 MG Injection [PSN] · remifentanil 2 MG Injection [SCD] · remifentanil (as remifentanil hydrochloride) 2 MG Injection [SY]36These highlights do not include all the information needed to use REMIFENTANIL HYDROCHLORIDE FOR INJECTION safely and effectively. See full prescribing information for REMIFENTANIL HYDROCHLORIDE FOR INJECTION. REMIFENTANIL HYDROCHLORIDE for injection, for intravenous use, CII Initial U.S. Approval: 199620240915
8b4c8696-e23e-4c51-a4d2-babab5bd945aremifentanil 2 MG Injection [PSN] · remifentanil 2 MG Injection [SCD] · remifentanil (as remifentanil hydrochloride) 2 MG Injection [SY]35These highlights do not include all the information needed to use ULTIVA safely and effectively. See full prescribing information for ULTIVA . ULTIVA ® (remifentanil hydrochloride), for injection, for intravenous use, CII Initial U.S. Approval: 199620251208
39284dec-b9bc-4fc8-b2d3-f1ef1323e5d4remifentanil 2 MG Injection [PSN] · remifentanil 2 MG Injection [SCD] · remifentanil (as remifentanil hydrochloride) 2 MG Injection [SY]34These highlights do not include all the information needed to use REMIFENTANIL HYDROCHLORIDE FOR INJECTION safely and effectively. See full prescribing information for REMIFENTANIL HYDROCHLORIDE FOR INJECTION. Remifentanil hydrochloride for injection, for intravenous use, CII Initial U.S. Approval: 199620240912
9d289052-1eb6-4ba2-a3ca-d2e542a052aeremifentanil 2 MG Injection [PSN] · remifentanil 2 MG Injection [SCD] · remifentanil (as remifentanil hydrochloride) 2 MG Injection [SY]34These highlights do not include all the information needed to use REMIFENTANIL HYDROCHLORIDE FOR INJECTION safely and effectively. See full prescribing information for REMIFENTANIL HYDROCHLORIDE FOR INJECTION. REMIFENTANIL HYDROCHLORIDE, for injection, for intravenous use, CII Initial U.S. Approval: 199620240101
4dbcb8f9-1987-4b66-bd2f-d251fda0be10remifentanil 2 MG Injection [PSN] · remifentanil 2 MG Injection [SCD] · remifentanil (as remifentanil hydrochloride) 2 MG Injection [SY]34These highlights do not include all the information needed to use ULTIVA safely and effectively. See full prescribing information for ULTIVA . ULTIVA ® (remifentanil hydrochloride), for injection, for intravenous use, CII Initial U.S. Approval: 199620231221